Finally, we found that the inhibition of C3/C3aR by an antagonist (SB 290157) improved the hydrocephalus and cognitive deficits induced by GMH-IVH, indicating that C3/C3aR was a novel and potential therapeutic target for PHH after GMH-IVH [33]. The gene discussed is C3AR1; the disease is Hydrocephalus.